Prelude Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$301K Buy
+23,160
New +$301K 0.03% 608
2024
Q4
Sell
-12,519
Closed -$291K 1080
2024
Q3
$291K Buy
12,519
+533
+4% +$12.4K 0.02% 795
2024
Q2
$292K Buy
+11,986
New +$292K 0.02% 726
2024
Q1
Sell
-9,359
Closed -$295K 1190
2023
Q4
$295K Buy
9,359
+897
+11% +$28.3K 0.02% 642
2023
Q3
$216K Sell
8,462
-364
-4% -$9.3K 0.01% 722
2023
Q2
$253K Sell
8,826
-3,768
-30% -$108K 0.02% 626
2023
Q1
$302K Buy
+12,594
New +$302K 0.02% 566
2022
Q3
Sell
-11,753
Closed -$185K 1474
2022
Q2
$185K Buy
+11,753
New +$185K 0.01% 1106
2021
Q1
Hold
0
1083
2020
Q4
Sell
-5,727
Closed -$246K 799
2020
Q3
$246K Sell
5,727
-2,073
-27% -$89K 0.01% 443
2020
Q2
$365K Sell
7,800
-23,539
-75% -$1.1M 0.02% 359
2020
Q1
$426K Buy
31,339
+478
+2% +$6.5K 0.03% 183
2019
Q4
$335K Buy
30,861
+8,231
+36% +$89.3K 0.01% 403
2019
Q3
$232K Buy
22,630
+5,113
+29% +$52.4K 0.01% 419
2019
Q2
$165K Sell
17,517
-7,272
-29% -$68.5K 0.01% 514
2019
Q1
$169K Buy
+24,789
New +$169K 0.01% 495
2018
Q3
Sell
-1,100
Closed -$9K 1350
2018
Q2
$9K Buy
+1,100
New +$9K ﹤0.01% 1211
2017
Q4
Sell
-1,171
Closed -$8K 1206
2017
Q3
$8K Buy
1,171
+1,157
+8,264% +$7.9K ﹤0.01% 1319
2017
Q2
$0 Buy
+14
New ﹤0.01% 1468
2016
Q3
Sell
-29
Closed -$1K 1503
2016
Q2
$1K Buy
+29
New +$1K ﹤0.01% 1469
2015
Q2
Hold
0
1580
2015
Q1
Hold
0
1838
2014
Q4
Sell
-29
Closed -$3K 1773
2014
Q3
$3K Sell
29
-357
-92% -$36.9K ﹤0.01% 1700
2014
Q2
$47K Sell
386
-785
-67% -$95.6K 0.01% 1228
2014
Q1
$149K Buy
+1,171
New +$149K 0.02% 736
2013
Q4
Sell
-200
Closed -$25K 1493
2013
Q3
$25K Buy
+200
New +$25K ﹤0.01% 1083